Work

A UGT1A1 genotype-guided dosing study of irinotecan in metastatic colorectal cancer (mCRC) patients (pts) treated with FOLFIRI plus bevacizumab (BEV).

Year: 2014

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2014.32.3_suppl.562

Authors: Manish Sharma, Giuseppe Toffoli, Angela Buonadonna, Elena Marangon, Blase N. Polite, Sergio Frustaci, Federico Innocenti

Institutions: University of Chicago, Centro di Riferimento Oncologico, University of North Carolina at Chapel Hill

Language: English

Topic: Pharmacogenetics and Drug Metabolism

Subfield: Pharmacology

Field: Pharmacology, Toxicology and Pharmaceutics

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2590284672

Cites:

Cited by:

Related to: 10